Invention Grant
- Patent Title: Use of a p38 kinase inhibitor for treating psychiatric disorders
- Patent Title (中): 使用p38激酶抑制剂治疗精神疾病
-
Application No.: US12305045Application Date: 2007-06-13
-
Publication No.: US07989479B2Publication Date: 2011-08-02
- Inventor: Mauro Corsi , Isidore Faiferman , Emilio Merlo Pich , Emiliangelo Ratti , Paul Bryan Wren
- Applicant: Mauro Corsi , Isidore Faiferman , Emilio Merlo Pich , Emiliangelo Ratti , Paul Bryan Wren
- Applicant Address: US PA Philadelphia
- Assignee: GlaxoSmithKline LLC
- Current Assignee: GlaxoSmithKline LLC
- Current Assignee Address: US PA Philadelphia
- Agent James P. Riek
- Priority: GB0612026.5 20060616
- International Application: PCT/EP2007/055858 WO 20070613
- International Announcement: WO2007/144390 WO 20071221
- Main IPC: A61K31/44
- IPC: A61K31/44
Abstract:
The use of 6-(S-Cyclopropylcarbamoyl-S-fluoro-2-methyl-phenyl)-N-(2,2-dimethylproyl)-nicotinamide, which is known in the art as a p38 kinase inhibitor in the treatment or prophlaxis of one or more psychiatric disorders.
Public/Granted literature
- US20100016377A1 Use of a p38 Kinase Inhibitor for Treating Psychiatric Disorders Public/Granted day:2010-01-21
Information query
